top of page
Periodic Table

Turning Inventions into Innovations


Drug Discovery


  • Structure-based drug design

  • Hit identification and validation

  • Hit to lead/lead optimization

  • Candidate selection criteria


Preclinical Development


  • Global CRO selection and management

  • Salt screening/salt selection

  • Physicochemical and solid state characterization

  • Non-GMP scale up and labelled-API for toxicology and bio-distribution evaluation

  • Preformulation and formulation development


Business Strategy


  • Development and research strategy

  • Preparation and review of scientific content for investor pitch decks, preliminary prospectus

  • Draft and review CDAs, NDAs, master service agreements, research partnership agreements

  • Scientific due diligence of companies for research or M&A opportunities

Chemistry, Manufacturing and Controls (CMC)


  • Global CMO selection and management

  • Drug substance and drug product stability protocols

  • Analytical method development and fit-for-purpose validation

  • cGMP drug substance and drug product manufacturing for Phase 1 and Phase 2 

  • Preparation and review CMC documentation for both FDA and Health Canada regulatory filings

Intellectual Property


  • Competitive landscape analysis

  • Draft and review of scientific content for patent filings


Areas of Expertise

Therapeutic Areas


  • Oncology

  • Antimicrobials

  • Inflammation

  • Rare diseases-nephrology & dermatology

  • Oral and topical medical cannabis product design and development




  • Natural products

  • Heterocyclic chemistry

  • Asymmetric chemistry

  • Nucleosides and Nucleotides

  • Peptides

  • CRISPR/Cas gene editing

Drug Targets


  • Kinases

  • Methyltransferases

  • G-protein coupled receptors (GPCRs)

  • Endocannabinoid system

  • Rare monogenic disorders


bottom of page